The MATTERS trial : safety and tolerability of whole-body hyperthermia at 41.50°C in combination with chemotherapy in metastatic cancer patients

Bron
Cancer research communications - ISSN 2767-9764-6:2 (2026) p. 273-283
Auteur(s)